Browsing: News

Galderma, a global dermatology company, has received filing acceptances for its breakthrough treatment nemolizumab. The drug is designed to treat prurigo nodularis and moderate-to-severe atopic dermatitis in adolescents and adults. It received regulatory nods from authorities in Australia, Singapore, Switzerland, and the United Kingdom via the Access Consortium framework.

In a relentless surge of scorching temperatures, Southeast Asia faces an unprecedented heatwave that is disrupting lives and livelihoods. Malaysia mourns the tragic heat-induced death of a three-year-old child, the second heat-related death this year. Meanwhile, Vietnam grapples with devastating agricultural droughts caused by the heatwave, and the Philippines sees schools close as temperatures hit a staggering 42 degrees Celsius.